In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients
Clinical trial NCT05617209 · COMPLETED
Trial details
- NCT number
- NCT05617209
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-07
- Primary completion
- 2023-01-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.